BIOLIFE SOLUTIONS INC — Director's Dealing 2024

Dec 6, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2024-12-02

Reporting Person: Werner Sean (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5089	Direct

Footnotes

F1: The amount represented in Column 2 of Table I includes 992 shares of the Company's common stock granted on September 9, 2021 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments, and 4,097 shares of restricted stock granted on February 24, 2022 pursuant to the Plan, which vests in equal quarterly installments.